Navigation Links
GW Pharmaceuticals Announces Pricing of Initial Public Offering on the NASDAQ Global Market
Date:5/1/2013

LONDON, May 1, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today the pricing of its initial public offering of 3,500,000 American Depository Shares ("ADSs") on the NASDAQ Global Market at a price of $8.90 per ADS. GW has also granted the Underwriters a 30-day option to purchase up to an additional 525,000 ADSs at the initial public offering price to cover over-allotments, if any. The shares are scheduled to begin trading on the NASDAQ Global Market today under the symbol "GWPH". Closing of the offering is expected to occur on May 7, 2013.

Lazard Capital Markets LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. Canaccord Genuity is acting as co-lead manager and Roth Capital Partners is acting as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on May 1, 2013. When available, copies of the final prospectus relating to this offering may be obtained from: Lazard Capital Markets LLC, Attn: Syndicate Department, 30 Rockefeller Plaza, 48th Floor, New York, NY 10020, Telephone: (800) 542-0970; from Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY,11717, Attn: Prospectus Department, Phone (631) 274-2806 / Fax (631) 254-7140; from Canaccord Genuity Inc., Attention: Syndicate Department, 99 High Street, 12th Floor, Boston, Massachusetts 02110, or by telephone at (617) 371-3900; and from Roth Capital Partners, LLC, Equity Capital Markets, 888 San Clemente Drive, Newport Beach, CA 92660, at 800-678-9147 and Rothecm@rot
'/>"/>

SOURCE GW Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
2. Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
3. Catabasis Pharmaceuticals Announces Issuance of Patents for CAT-1000 and CAT-2000 Series
4. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
5. Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
6. Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
7. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
8. Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
9. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
10. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
11. Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015  CytRx Corporation (Nasdaq: ... company specializing in oncology, today announced an interim ... combination studies pairing aldoxorubicin with either gemcitabine or ... or ifosfamide with escalating doses of aldoxorubicin. The ... at the lowest dose level of aldoxorubicin (170 ...
(Date:5/4/2015)... 4, 2015 Unchained Labs, a refreshingly new ... year,s PEGS conference and launches the UNit — the ... PEGS: The Essential Protein Engineering Summit takes place in ... The UNit lets drug discovery researchers look at ... there. Its 7 applications, 144 sample a day throughput ...
(Date:5/4/2015)... May 4, 2015  Geneia, a company of ... solutions to improve healthcare efficiencies, today announced a ... Center (BNRC) use Geneia,s advanced analytics solution ... the quality and lower the cost of patient ... outcomes, claims and utilization data from multiple sources ...
Breaking Medicine Technology:CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 4CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 5CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 6CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 7Unchained Labs Lets the UNit Loose 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3
... MAQUET Cardiovascular, a global leading provider of ... U.S. Federal Trade Commission (FTC) approval to acquire ... technologies for interventional cardiology and radiology, chest trauma ... surgery, and has subsequently closed the previously announced ...
... YORK, Nov. 7, 2011 Reportlinker.com ... report is available in its catalogue: ... X-Ray, Digital X-Ray, CT and Other ... http://www.reportlinker.com/p0681346/Medical-Imaging-Markets-X-Ray-Digital-X-Ray-CT-and-Other-Radiography-Systems.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging Radiography ...
Cached Medicine Technology:MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation 2MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation 3Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems 2Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems 3Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems 4Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems 5Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems 6
(Date:5/4/2015)... (PRWEB) May 04, 2015 Johnson & Wales ... million engineering and science academic center on Wednesday, April 22. ... ground for land made available by the re-alignment of Interstate-195. ... corner of Friendship and Chestnut streets in Providence, is scheduled ... on a parcel of land the university purchased in 2012. ...
(Date:5/4/2015)... Healthcare Solutions is proud to be a sponsor at ... in Baltimore, MD from May 11 – 13, 2015. ... opportunity for clients to gather to network, attend educational ... to sponsoring the event, TROY Healthcare Solutions will be ... can stop by the TROY booth and see sample ...
(Date:5/4/2015)... May 04, 2015 The American Telemedicine ... state policy reports which identify gaps in coverage and ... ATA issued the State Telemedicine Gaps Reports last September, ... their laws and regulations impact healthcare delivery in their ... result of state actions across the nation, ATA reevaluated ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Baptist ... Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold ... Stroke Honor Roll. The award recognizes the hospital’s ... receive the most appropriate treatment according to nationally ... evidence. , To receive the Gold Plus Quality ...
(Date:5/4/2015)... METTLER TOLEDO has announced an upcoming ... in a GXP Regulated Laboratory ", featuring independent ... will be presented on May 27, 2015 at ... a critical component of pharmaceutical product quality and ... recent years an increasing number of inspections have ...
Breaking Medicine News(10 mins):Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2
... , THURSDAY, March 3 (HealthDay News) -- More than ... a night, which affects their concentration and general health, ... work performance and the ability to drive safely, found ... Prevention (CDC), which published two sleep studies March 4 ...
... 3 (HealthDay News) -- An analysis of breast tissue may ... a new study reports. Researchers analyzed what they describe ... found that the way collagen fibers -- the main component ... patient,s diagnosis and help determine treatment. Collagen not only ...
... The burning, tingling pain of neuropathy may affect feet ... of nerve cells that supply the extremities age and ... these areas, Johns Hopkins scientists suggest in a new ... to fight neuropathy, a condition that often accompanies other ...
... (HealthDay News) -- Bunions, a common but painful deformity of the ... a new study has found. And the more severe the ... other parts of the body, leading to declines in both general ... is a bump that develops on the side of the big ...
... The American Thoracic Society has released a new report ... immunodeficiency virus (HIV)-associated pulmonary disease. The report examines the ... areas where combination antiretroviral therapies (ART) are available, as ... areas of the world where ART use is limited. ...
... tuberculosis (TB) bacteria develop multi-drug tolerance point to ways TB ... be published April 1 in the journal Cell . ... for drug tolerance that is induced in the TB bacteria ... requires a complex, long-term curative regimen of at least six ...
Cached Medicine News:Health News:1 in 3 Americans Gets Less Than 7 Hours of Sleep: CDC 2Health News:1 in 3 Americans Gets Less Than 7 Hours of Sleep: CDC 3Health News:Tissue Analysis May Help Predict Breast Cancer Outcome 2Health News:Feet first? Old mitochondria might be responsible for neuropathy in the extremities 2Health News:Feet first? Old mitochondria might be responsible for neuropathy in the extremities 3Health News:ATS issues report on emerging issues in HIV-associated pulmonary disease 2Health News:ATS issues report on emerging issues in HIV-associated pulmonary disease 3Health News:New findings on drug tolerance in TB suggest ideas for shorter cures 2Health News:New findings on drug tolerance in TB suggest ideas for shorter cures 3
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
1000 L, Bulk Recommended for 500 and 1000 L pipettes...
Conducting disposable filter-tips....
300 L, Bulk Recommended for 250 and 300 L pipettes....
Medicine Products: